We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
-4.28%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$1.33B
AUM Growth
-$60.7M
Cap. Flow
+$29.7M
Cap. Flow %
2.24%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
BTRS
BTRS Holdings Inc. Class 1 Common Stock
BTRS
+$22.9M
2
IMDX
Insight Molecular Diagnostics
IMDX
+$6.83M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 51.82%
2 Consumer Staples 32.54%
3 Miscellaneous 8.81%
4 Industrials 5.34%
5 Technology 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.14B
$609M 45.94%
8,592,007
– –
MNST icon
2
Monster Beverage
MNST
$87.5B
$432M 32.54%
18,625,952
– –
IWM icon
3
iShares Russell 2000 ETF
IWM
$76.1B
$117M 8.81%
690,000
– –
AXON
4
Axon Enterprise
AXON
$38.1B
$70.8M 5.34%
760,062
– –
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$263M
$55.2M 4.16%
34,935,485
– –
IMDX
6
Insight Molecular Diagnostics
IMDX
$118M
$21M 1.58%
1,167,685
+300,188
+35% +$6.83M
BTRS
7
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
$19.8M 1.49%
+3,977,701
New +$22.9M
SER icon
8
Serina Therapeutics
SER
$56.4M
$1.73M 0.13%
85,219
– –

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.91B AUM 19.99% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Broadwood Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Broadwood Capital held 8 positions worth $1.33B, down 4.4% from $1.39B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital's Q2 2022 filing shows 1 new and 1 increased positions. Its largest new stake was BTRS Holdings Inc. Class 1 Common Stock: 3,977,701 shares worth $19.8M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 55% a quarter earlier, followed by Consumer Staples and Miscellaneous.

  • Broadwood Capital's largest Q2 2022 buy was BTRS Holdings Inc. Class 1 Common Stock: 3,977,701 shares worth $19.8M.
  • Broadwood Capital added most to Insight Molecular Diagnostics in Q2 2022, an estimated $6.83M increase.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.33B portfolio in Q2 2022.
  • Broadwood Capital opened 1 new position and closed 0 in Q2 2022.
  • Broadwood Capital's portfolio value fell 4.4% quarter-over-quarter to $1.33B.

Based on Broadwood Capital's 13F filing for Q2 2022, filed 15 Aug 2022.